Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Irvine Pharmaceutical Services, a pharmaceutical development company, has announced the January 2009 launch of Avrio Biopharmaceuticals. This venture is said to be part of Irvine's overall growth strategy focused on improving its services and product offerings to current and potential clients.
Subscribe to our email newsletter
Avrio Biopharma will provide a full range of formulation development and aseptic fill-and-finish services. It will be focused on developing optimized production processes and providing dependable filling, lyophilization and packaging capabilities for early phase clinical trial materials, the company said.
Assad Kazeminy, CEO and founder of Irvine Pharmaceutical Services, said: “We are very excited about this extension of our company. Avrio will help round out our existing capabilities and its connection to Irvine will also make it possible to provide our clients with broader services via seamless partnership.”